AAIC 2015 Press Briefing, 7/22/15: Drug Treatments/Developing Topics 1 (Part 4 of 5)

At the Alzheimer’s Association International Conference® 2015 (AAIC®), Jeff Sevigny, M.D., senior director of clinical development at Biogen Idec, talks about findings from PRIME, the Phase 1b study of the experimental drug aducanumab.